Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Validation of the triple timed up-and-go test in Lambert-Eaton myasthenia.

Raja SM, Sanders DB, Juel VC, Harati Y, Smith AG, Pascuzzi R, Richman DP, Wu A, Aleš KL, Jacobus LR, Jacobus DP, Guptill JT; DAPPER Study Team.

Muscle Nerve. 2019 Sep;60(3):292-298. doi: 10.1002/mus.26625. Epub 2019 Jul 18.

PMID:
31269226
2.

Novel valosin-containing protein mutations associated with multisystem proteinopathy.

Al-Tahan S, Al-Obeidi E, Yoshioka H, Lakatos A, Weiss L, Grafe M, Palmio J, Wicklund M, Harati Y, Omizo M, Udd B, Kimonis V.

Neuromuscul Disord. 2018 Jun;28(6):491-501. doi: 10.1016/j.nmd.2018.04.007. Epub 2018 Apr 17.

PMID:
29754758
3.

Reply.

Sanders DB, Harati Y, Juel VC, Lou JS, Marburger T, Pascuzzi RM, Peltier AC, Richman DP, Smith AG.

Muscle Nerve. 2018 May;57(5):E130-E131. doi: 10.1002/mus.26089. Epub 2018 Mar 1. No abstract available.

PMID:
29406616
4.

3,4-diaminopyridine base effectively treats the weakness of Lambert-Eaton myasthenia.

Sanders DB, Juel VC, Harati Y, Smith AG, Peltier AC, Marburger T, Lou JS, Pascuzzi RM, Richman DP, Xie T, Demmel V, Jacobus LR, Aleš KL, Jacobus DP; Dapper Study Team.

Muscle Nerve. 2018 Apr;57(4):561-568. doi: 10.1002/mus.26052. Epub 2018 Feb 2.

5.

Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine.

Burns TM, Smith GA, Allen JA, Amato AA, Arnold WD, Barohn R, Benatar M, Bird SJ, Bromberg M, Chahin N, Ciafaloni E, Cohen JA, Corse A, Crum BA, David WS, Dimberg E, Sousa EA, Donofrio PD, Dyck PJ, Engel AG, Ensrud ER, Ferrante M, Freimer M, Gable KL, Gibson S, Gilchrist JM, Goldstein JM, Gooch CL, Goodman BP, Gorelov D, Gospe SM Jr, Goyal NA, Guidon AC, Guptill JT, Gutmann L, Gutmann L, Gwathmey K, Harati Y, Harper CM Jr, Hehir MK, Hobson-Webb LD, Howard JF Jr, Jackson CE, Johnson N, Jones SM, Juel VC, Kaminski HJ, Karam C, Kennelly KD, Khella S, Khoury J, Kincaid JC, Kissel JT, Kolb N, Lacomis D, Ladha S, Larriviere D, Lewis RA, Li Y, Litchy WJ, Logigian E, Lou JS, MacGowen DJ, Maselli R, Massey JM, Mauermann ML, Mathews KD, Meriggioli MN, Miller RG, Moon JS, Mozaffar T, Nations SP, Nowak RJ, Ostrow LW, Pascuzzi RM, Peltier A, Ruzhansky K, Richman DP, Ross MA, Rubin DI, Russell JA, Sachs GM, Salajegheh MK, Saperstein DS, Scelsa S, Selcen D, Shaibani A, Shieh PB, Silvestri NJ, Singleton JR, Smith BE, So YT, Solorzano G, Sorenson EJ, Srinivasen J, Tavee J, Tawil R, Thaisetthawatkul P, Thornton C, Trivedi J, Vernino S, Wang AK, Webb TA, Weiss MD, Windebank AJ, Wolfe GI.

Muscle Nerve. 2016 Feb;53(2):165-8. doi: 10.1002/mus.25009. Epub 2015 Dec 21. No abstract available.

PMID:
26662952
6.

Amyotrophic lateral sclerosis with positive anti-acetylcholine receptor antibodies. Case report and review of the literature.

Mehanna R, Patton EL Jr, Phan CL, Harati Y.

J Clin Neuromuscul Dis. 2012 Dec;14(2):82-5. doi: 10.1097/CND.0b013e31824db163. Review.

PMID:
23172389
7.

Cognition, behavior, and respiratory function in amyotrophic lateral sclerosis.

Strutt AM, Palcic J, Wager JG, Titus C, Macadam C, Brown J, Scott BM, Harati Y, Schulz PE, York MK.

ISRN Neurol. 2012;2012:912123. doi: 10.5402/2012/912123. Epub 2012 Jul 17.

8.

Comparison of sudomotor and sensory nerve testing in painful sensory neuropathies.

Killian JM, Smyth S, Guerra R, Adhikari I, Harati Y.

J Clin Neuromuscul Dis. 2011 Mar;12(3):138-42. doi: 10.1097/CND.0b013e318209efb1.

PMID:
21321492
9.

Peripheral Nerve Society Guideline on processing and evaluation of nerve biopsies.

Sommer CL, Brandner S, Dyck PJ, Harati Y, LaCroix C, Lammens M, Magy L, Mellgren SI, Morbin M, Navarro C, Powell HC, Schenone AE, Tan E, Urtizberea A, Weis J; Peripheral Nerve Society.

J Peripher Nerv Syst. 2010 Sep;15(3):164-75. doi: 10.1111/j.1529-8027.2010.00276.x.

PMID:
21040138
10.

Diabetic peripheral neuropathies.

Harati Y.

Methodist Debakey Cardiovasc J. 2010 Apr-Jun;6(2):15-9. Review. No abstract available.

PMID:
20661188
11.

A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS.

Jawaid A, Murthy SB, Wilson AM, Qureshi SU, Amro MJ, Wheaton M, Simpson E, Harati Y, Strutt AM, York MK, Schulz PE.

Amyotroph Lateral Scler. 2010 Dec;11(6):542-8. doi: 10.3109/17482968.2010.482592. Epub 2010 May 26.

PMID:
20500116
12.

Frontal and temporal lobe involvement on verbal fluency measures in amyotrophic lateral sclerosis.

Lepow L, Van Sweringen J, Strutt AM, Jawaid A, MacAdam C, Harati Y, Schulz PE, York MK.

J Clin Exp Neuropsychol. 2010 Nov;32(9):913-22. doi: 10.1080/13803391003596439. Epub 2010 Apr 13.

PMID:
20390792
13.

What's in the Literature?

Harati Y.

J Clin Neuromuscul Dis. 2009 Dec;11(2):88-95. doi: 10.1097/CND.0b013e3181c75e35. Review.

PMID:
19955991
14.

Mutilating acral ulcers: the spectrum of differential diagnosis.

Izadyar S, Kwan JY, Gundogdu BM, Phan CL, Harati Y.

J Clin Neuromuscul Dis. 2009 Mar;10(3):126-34. doi: 10.1097/CND.0b013e318196f0b2.

PMID:
19258859
15.

The amyotrophic lateral sclerosis 8 protein VAPB is cleaved, secreted, and acts as a ligand for Eph receptors.

Tsuda H, Han SM, Yang Y, Tong C, Lin YQ, Mohan K, Haueter C, Zoghbi A, Harati Y, Kwan J, Miller MA, Bellen HJ.

Cell. 2008 Jun 13;133(6):963-77. doi: 10.1016/j.cell.2008.04.039.

16.

Diabetic neuropathies: unanswered questions.

Harati Y.

Neurol Clin. 2007 Feb;25(1):303-17. Review.

PMID:
17324729
17.

Myeloneuropathic presentation of spinal epidural lipomatosis.

Izadyar S, Kwan JY, Harati Y.

J Clin Neuromuscul Dis. 2006 Mar;7(3):133-40. doi: 10.1097/01.cnd.0000211400.12372.d3.

PMID:
19078799
18.

West Nile virus infection after cardiac transplantation.

Murtagh B, Wadia Y, Messner G, Allison P, Harati Y, Delgado R.

J Heart Lung Transplant. 2005 Jun;24(6):774-6.

PMID:
15949740
19.

Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes.

Andersen PM, Sims KB, Xin WW, Kiely R, O'Neill G, Ravits J, Pioro E, Harati Y, Brower RD, Levine JS, Heinicke HU, Seltzer W, Boss M, Brown RH Jr.

Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Jun;4(2):62-73.

PMID:
14506936
20.

Occurrence of amyotrophic lateral sclerosis among Gulf War veterans.

Horner RD, Kamins KG, Feussner JR, Grambow SC, Hoff-Lindquist J, Harati Y, Mitsumoto H, Pascuzzi R, Spencer PS, Tim R, Howard D, Smith TC, Ryan MA, Coffman CJ, Kasarskis EJ.

Neurology. 2003 Sep 23;61(6):742-9. Review. Erratum in: Neurology. 2003 Nov 11;61(9):1320.

PMID:
14504315
21.

Clinical and genetic heterogeneity in progressive external ophthalmoplegia due to mutations in polymerase gamma.

Filosto M, Mancuso M, Nishigaki Y, Pancrudo J, Harati Y, Gooch C, Mankodi A, Bayne L, Bonilla E, Shanske S, Hirano M, DiMauro S.

Arch Neurol. 2003 Sep;60(9):1279-84.

PMID:
12975295
22.

Neuromuscular highlights from the american academy of neurology annual meeting.

Bromberg MB, Harati Y.

J Clin Neuromuscul Dis. 2001 Sep;3(1):39-44. No abstract available.

PMID:
19078653
23.

Current management of ALS: comparison of the ALS CARE Database and the AAN Practice Parameter. The American Academy of Neurology.

Bradley WG, Anderson F, Bromberg M, Gutmann L, Harati Y, Ross M, Miller RG; ALS CARE Study Group.

Neurology. 2001 Aug 14;57(3):500-4.

PMID:
11502920
24.

Motor unit number estimation, ALS and clinical trials.

Gooch CL, Harati Y.

Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Mar;1(2):71-82. Review.

PMID:
11467053
25.

Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy.

Mendell JR, Barohn RJ, Freimer ML, Kissel JT, King W, Nagaraja HN, Rice R, Campbell WW, Donofrio PD, Jackson CE, Lewis RA, Shy M, Simpson DM, Parry GJ, Rivner MH, Thornton CA, Bromberg MB, Tandan R, Harati Y, Giuliani MJ; Working Group on Peripheral Neuropathy.

Neurology. 2001 Feb 27;56(4):445-9.

PMID:
11222785
26.

A "dystrophic" variant of autosomal recessive myotonia congenita caused by novel mutations in the CLCN1 gene.

Nagamitsu S, Matsuura T, Khajavi M, Armstrong R, Gooch C, Harati Y, Ashizawa T.

Neurology. 2000 Dec 12;55(11):1697-703.

PMID:
11113225
27.

Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy.

Harati Y, Gooch C, Swenson M, Edelman SV, Greene D, Raskin P, Donofrio P, Cornblath D, Olson WH, Kamin M.

J Diabetes Complications. 2000 Mar-Apr;14(2):65-70.

PMID:
10959067
28.
29.

Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy.

Harati Y, Gooch C, Swenson M, Edelman S, Greene D, Raskin P, Donofrio P, Cornblath D, Sachdeo R, Siu CO, Kamin M.

Neurology. 1998 Jun;50(6):1842-6.

PMID:
9633738
30.

Side effects of immunosuppressant therapies used in neurology.

Machkhas H, Harati Y.

Neurol Clin. 1998 Feb;16(1):171-88. Review.

PMID:
9421547
31.

A mild case of Friedreich ataxia: lymphocyte and sural nerve analysis for GAA repeat length reveals somatic mosaicism.

Machkhas H, Bidichandani SI, Patel PI, Harati Y.

Muscle Nerve. 1998 Mar;21(3):390-3.

PMID:
9486868
32.

Moving toes and myoclonus associated with hereditary neuropathy with liability to pressure palsy (HNPP).

Shaibani A, Gooch C, Harati Y.

Muscle Nerve. 1997 Jul;20(7):881-3.

PMID:
9179161
33.

Longitudinal tracking of the same single motor unit in amyotrophic lateral sclerosis.

Gooch CL, Harati Y.

Muscle Nerve. 1997 Apr;20(4):511-3. No abstract available.

PMID:
9121513
34.

Clinical trials of riluzole in patients with ALS. ALS/Riluzole Study Group-II.

Miller RG, Bouchard JP, Duquette P, Eisen A, Gelinas D, Harati Y, Munsat TL, Powe L, Rothstein J, Salzman P, Sufit RL.

Neurology. 1996 Oct;47(4 Suppl 2):S86-90; discussion S90-2.

PMID:
8858057
35.

Diabetes and the nervous system.

Harati Y.

Endocrinol Metab Clin North Am. 1996 Jun;25(2):325-59. Review.

PMID:
8799703
36.

Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis.

Siklós L, Engelhardt J, Harati Y, Smith RG, Joó F, Appel SH.

Ann Neurol. 1996 Feb;39(2):203-16.

PMID:
8967752
37.

Cumulative reduction in serum cholinesterase following repeated therapeutic plasma exchange.

Collard CD, Baker BW 3rd, Johnson D, Bressler R, Harati Y.

J Clin Anesth. 1996 Feb;8(1):44-8.

PMID:
8695079
38.

Localization of myotonic dystrophy protein kinase in skeletal muscle and its alteration with disease.

Dunne PW, Ma L, Casey DL, Harati Y, Epstein HF.

Cell Motil Cytoskeleton. 1996;33(1):52-63.

PMID:
8824734
39.

Altered muscle calcium channel binding kinetics in autoimmune motoneuron disease.

Smith RG, Kimura F, Harati Y, McKinley K, Stefani E, Appel SH.

Muscle Nerve. 1995 Jun;18(6):620-7.

PMID:
7753125
40.

Aseptic meningitis and intravenous immunoglobulin therapy.

Harati Y, Shaibani AI.

Ann Intern Med. 1995 Feb 15;122(4):316. No abstract available.

PMID:
7825774
41.

Muscle mitochondrial ATP production in progressive supranuclear palsy.

Di Monte DA, Harati Y, Jankovic J, Sandy MS, Jewell SA, Langston JW.

J Neurochem. 1994 Apr;62(4):1631-4.

PMID:
8133289
42.

Somatic instability of CTG repeat in myotonic dystrophy.

Ashizawa T, Dubel JR, Harati Y.

Neurology. 1993 Dec;43(12):2674-8.

PMID:
8255475
43.

Chronic immune activation in the eosinophilia-myalgia syndrome.

McKinley KL, Harati Y, Schneider LW.

Muscle Nerve. 1993 Sep;16(9):947-51.

PMID:
8355725
44.

Decreased polyphosphoinositide metabolism accompanies myelinated fiber loss in human peripheral neuropathies.

Berti-Mattera LN, Harati Y, Eichberg J.

Mol Chem Neuropathol. 1992 Dec;17(3):201-8.

PMID:
1337252
45.

Tryptophan metabolism via the kynurenine pathway in patients with the eosinophilia-myalgia syndrome.

Silver RM, McKinley K, Smith EA, Quearry B, Harati Y, Sternberg EM, Heyes MP.

Arthritis Rheum. 1992 Sep;35(9):1097-105.

PMID:
1418026
46.

Frequently asked questions about diabetic peripheral neuropathies.

Harati Y.

Neurol Clin. 1992 Aug;10(3):783-807. Review.

PMID:
1323753
47.

Clinical features of Todd's post-epileptic paralysis.

Rolak LA, Rutecki P, Ashizawa T, Harati Y.

J Neurol Neurosurg Psychiatry. 1992 Jan;55(1):63-4.

48.

Effects of cyclosporine therapy on plasma lipoprotein levels.

Ballantyne CM, Podet EJ, Patsch WP, Harati Y, Appel V, Gotto AM Jr, Young JB.

JAMA. 1989 Jul 7;262(1):53-6.

PMID:
2733125
49.

Muscle pain associated with tubular aggregates and structures resembling cylindrical spirals.

Danon MJ, Carpenter S, Harati Y.

Muscle Nerve. 1989 Apr;12(4):265-72.

PMID:
2770779
50.

A double-blind study of the effectiveness of cyclosporine in amyotrophic lateral sclerosis.

Appel SH, Stewart SS, Appel V, Harati Y, Mietlowski W, Weiss W, Belendiuk GW.

Arch Neurol. 1988 Apr;45(4):381-6.

PMID:
3281637

Supplemental Content

Loading ...
Support Center